An Open-label Study to Determine the Excretion, Balance and Pharmacokinetics of SB649868 After a Single Oral Administration of 14C-SB649868 in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs GSK 649868 (Primary)
- Indications Sleep disorders
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 18 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Aug 2007 New trial record.